Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma
Status:
Completed
Trial end date:
2016-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to gather information on the effectiveness and
tolerability of a novel composition of existing U.S. Food and Drug Administration (FDA)
approved topical medications for the treatment of moderate to severe melasma.